Quarterly report pursuant to Section 13 or 15(d)

Subsequent Event

Subsequent Event
6 Months Ended
Jun. 30, 2016
Subsequent Events [Abstract]  
Subsequent Event

11. Subsequent Event

In July 2016, we granted 350,000 stock options to employees, of which 327,000 included vesting conditions associated with achievement of certain clinical development and capital raising milestones through 2016.